NASDAQ: LGVN - Longeveron Inc.

Yield per half year: -18.56%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Longeveron Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Longeveron Inc.

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, an allogeneic medicinal signaling cell therapy product isolated from the bone marrow of young, healthy adult donors. It is conducting Phase 1, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome.

more details
The company was incorporated in 2014 and is headquartered in Miami, Florida.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-02-12
ISIN US54303L1044
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://longeveron.com
Цена ао 1.72
Change price per day: -7.06% (1.7)
Change price per week: -14.59% (1.85)
Change price per month: +4.64% (1.51)
Change price per 3 month: -9.71% (1.75)
Change price per half year: -18.56% (1.94)
Change price per year: -51.38% (3.25)
Change price per 3 year: -77.81% (7.12)
Change price per year to date: -1.25% (1.6)
All parameters

Underestimation

Title Value Grade
P/S 44.76 1
P/BV 4.64 3
P/E 0 0
EV/EBITDA -1.44 0
Total: 3.5

Efficiency

Title Value Grade
ROA, % -175.83 0
ROE, % -313.01 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.1016 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % -87.34 0
Yield Ebitda, % 811.82 10
Yield EPS, % 5168.39 10
Total: 8
More

Institutions Volume Share, %
Armistice Capital, LLC 183600 17.75
Vanguard Group Inc 19098 1.85
Blackrock Inc. 11170 1.08
Creative Planning 10932 1.06
Geode Capital Management, LLC 9024 0.87
Northern Trust Corporation 4976 0.48
Citadel Advisors Llc 3225 0.31
One Wealth Management Investment & Advisory Services, LLC 1492 0.14
State Street Corporation 1480 0.14
TOWNSQUARE CAPITAL LLC 1445 0.14



Head Job title Payment Year of birth
Mr. Paul T. Lehr J.D. International Executive Director, General Counsel & Secretary 554.05k 1968 (57 years)
Dr. Dan Gincel Ph.D. Senior Vice President of Strategic Collaborations & Scientific Affairs N/A 1971 (54 years)
Dr. Joshua Michael Hare FACC, M.D. Co-Founder, Chief Science Officer & Chairman 74k 1963 (62 years)
Ms. Lisa A. Locklear M.B.A. CFO & Treasurer 248.38k 1961 (64 years)
Ms. Elly Ryu VP & Corporate Controller N/A 1981 (44 years)
Mr. Mohamed Wa'el Ahmed Hashad M.B.A. CEO & Director 1962 (63 years)
Dr. Nataliya Agafonova M.D. Chief Medical Officer 1969 (56 years)
Mr. Michael Mannarino VP & Corporate Controller
Ms. Lisa McClain-Moss Vice President of Manufacturing 1971 (54 years)
Mr. Brian G Rash Ph.D. VP of Research & Discovery

Address: United States, Miami. FL, Life Science and Technology Park - open in Google maps, open in Yandex maps
Website: https://longeveron.com